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Available online 17 December 2015AbstractThe purpose of this investigation was to study the viral aetiology of influenza-like illness (ILI) and acute respiratory tract infection (ARTI)
among patients requiring intensive care unit admission.
A cross-sectional retrospective study was carried out in Sicily over a 4-year period. A total of 233 respiratory samples of patients with ILI/
ARTI admitted to intensive care units were molecularly analyzed for the detection of a comprehensive panel of aetiologic agents of viral
respiratory infections.
About 45% of patients was positive for at least one pathogen. Single aetiology occurred in 75.2% of infected patients, while polymicrobial
infection was found in 24.8% of positive subjects. Influenza was the most common aetiologic agent (55.7%), especially among adults. Most of
patients with multiple aetiology (76.9%) were adults and elderly. Mortality rates among patients with negative or positive aetiology did not
significantly differ (52.4% and 47.6%, respectively).
Highly transmissible respiratory pathogens are frequently detected among patients with ILI/ARTI admitted in intensive care units, showing
the occurrence of concurrent infections by different viruses. The knowledge of the circulation of several types of microorganisms is of crucial
importance in terms of appropriateness of therapies, but also for the implication in prevention strategies and hospital epidemiology.
© 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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particularly in developing countries [1].
Moreover, the elderly or the immunocompromised subjects
with influenza-like illness (ILI) or ARTI are at higher risk for
exacerbations in pre-existing chronic conditions or progres-
sion to respiratory complications, which can be responsible of
hospitalization and admission to an intensive care unit (ICU).
It has been demonstrated that several pathogens are
implicated in ILI/ARTI, either of viral or bacterial origin,
although specific aetiology often goes undiagnosed [2,3]. Pa-
tients with acute respiratory illness admitted to the ICU, are
usually monitored following a standard approach consisting of
routine culture and testing of the bacterial agents commonly
responsible of community-acquired pneumonia. Conversely,reserved.
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relevance [4] and laboratory detection is often used as second-
line diagnostics or limited to patients negative for other bac-
terial pathogens, consequently leading to a delayed adminis-
tration of potentially beneficial antiviral drugs [5].
Additionally, it is well-known that patients showing acute
febrile respiratory illnesses may facilitate the spread of in-
fectious agents, especially during the early phase of the dis-
ease, often sustained by aerosol-generating procedures able to
favor patient-to-patient dissemination in ICU [6] or to
healthcare workers (HCWs), visitors, and ultimately the
community. This evidence can be further enhanced by well
documented low vaccination coverage rates among HCWs
versus influenza or other preventable infectious respiratory
diseases [7,8], as well as by an inappropriate habit of working
while symptomatic for ILI [9].
Although the impact of influenza infection in intensive care
wards have been previously described, particularly during the
2009H1N1 influenza pandemic [10], only a limited number of
studies have focused on the complex aetiology of ILI/ARTIs in
critically ill patients admitted to an ICU.
In this context, a better understanding of a wide spectrum
of viral respiratory pathogens causing acute infections among
hospitalized patients in these settings is essential for
improving preventive and therapeutic strategies and priori-
tizing diagnostic efforts.
The purpose of this a 4-year cross-sectional study was to
evaluate the burden of ILIs and/or ARTIs among hospitalized
patients admitted to intensive care units in Sicily and to
determine the specific aetiology of respiratory infections.
2. Materials and methods2.1. Study design and settingsA cross-sectional retrospective study was carried out, from
July 2009 to December 2012, on 253 different biological
samples (oropharyngeal swabs or bronco-alveolar lavages for
intubated patients) consecutively collected from patients
admitted to intensive care unit with clinical symptoms of ILI/
ARTI. ILI and ARTI were defined according to the European
Centre for Disease Prevention and Control (ECDC) (http://
ecdc.europa.eu/en/healthtopics/influenza/surveillance/Pages/
influenza_case_definitions.aspx; accessed: 17/11/2015).
Twenty-two different hospitals located in Sicily, an Italian
region with a population of over 5 million people (http://demo.
istat.it/pop2013/index.html) participated to the study.
On the basis of the current national healthcare system of
Italy, patients were stratified in three different age-groups:
14 years, 15e64 years, and 65 years (pediatric, adult,
and elderly patients, respectively).
A cross-linkage with the Hospital Discharge Records
(HDRs) available for the Sicilian Region (Regional Department
of Health, Epidemiological Observatory) was performed in
order to confirm all information or to obtain additional epide-
miological data concerning International Classification of
Disease (ICD9-CM) codes, length of hospital stay, and deaths.Consequently, the study population consisted of patients
admitted to ICUs with ILI/ARTI clinical symptoms for whom
HDRs included ICD9-CM codes suggestive of ILI/ARTI as
primary or secondary diagnosis. The final coding set was
selected according to Marsden-Haug and colleagues [11] with
the inclusion of ICD9-CM codes for ARTI (i.e. 481, 482.x).2.2. Detection of respiratory pathogensEach respiratory specimen was transported at 4 C and
stored at 80 C upon arrival before processing at the labo-
ratory of the Clinical Epidemiology Unit of the University
Hospital “P. Giaccone” in Palermo (Sicily, Italy).
Samples were analysed for the detection of specific viral
genomes belonging to human Respiratory Syncytial virus type
A (hRSV-A) and B (hRSV-B), Parainfluenza virus 1e4 (hPIV-
1/4), Metapneumovirus A (hMPV-A) and B (hMPV-B),
Coronavirus OC43 (hCoV-OC43), HKU1 (hCoV-HKU1),
NL63 (hCoV-NL63) and 229E (hCoV-229E), Enteroviruses
(hEV), Rhinoviruses (hRV), Parechovirus (hPeV), Influenza
viruses type A (FluA), B (FluB) and C (FluC), Bocavirus 1e4
(hBoV-1/4), Adenoviruses (hAdV), WU and KI Poly-
omaviruses (WUPyV and KIPyV). Nucleic acids were
extracted from 140 mL of each sample using the QIAamp Viral
RNA Mini Kit or the QIAamp DNA Mini Kit (QIAGEN,
Milan, Italy) according to manufacturer's protocol.
The detection of respiratory pathogens was performed with
singleplex real-time PCR (rPCR) assays using the TaqMan
technology and run on a 7000 Real-Time PCR System plat-
form (Applied Biosystems, Life Technologies); primers and
probes sets are described in Supplementary Table 1.
For the detection of RNA viruses, we performed RT-rPCR
as a single step using the Superscript III® Platinum® one-
step Quantitative RT-PCR System (Invitrogen, Life Technol-
ogies), while for DNA viruses, the Platinum® Quantitative
PCR Supermix-UDG with ROX (Invitrogen, Life Technolo-
gies) was used according to manufacturer's instruction.
Each run included positive and negative controls for each
target. For FluA and FluB RT-rPCR assays wild type viruses
were used as positive controls, whereas for each other target a
plasmid standard was used, after cloning into TOPO® TA
vector (Life Technologies) a synthetic construct (GeneArt®
Gene Synthesis, Life Technologies) or a PCR product.2.3. Data analysisDescriptive statistics were calculated to explore both the
burden of ILI/ARTI among ICU patients and the distribution
of single and multiple aetiology by gender, age, length of
hospital stay, and adverse outcomes.
Categorical variables were described as frequencies and
percentages and were compared with the chi-square test or
Fisher's exact test where appropriate. Continuous variables
were presented as the median and interquartile range and
compared using the Student t test once normality was
demonstrated; otherwise, the nonparametric ManneWhitney
U test was performed. CochraneArmitage test for trend was
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tests were two-tailed and a p-value of 0.05 was considered
statistically significant. All analyses were performed with
STATA version 12.1 for Macintosh (Apple) [12].2.4. Ethics statementThe present work was reviewed and approved by the
institutional review board of the University Hospital “P.
Giaccone” of Palermo, health data were stored according to
the Italian laws on privacy, and the research was conducted
following the Helsinki declaration statements. A written
informed consent was waived due to the non-interventional
design.
3. Results
A schematic diagram of inclusion/exclusion criteria used
for the selection of study/reference populations is depicted in
Fig. 1.
According to the HDRs database of Sicily, a total of
3,141,936 admissions were recorded during the study period, of
which 67.1% (n ¼ 2,104,609/3,141,936) were regular hospital
admissions and about one-half (54.0%; n ¼ 1,138,092/
2,107,609) were through Emergency Departments (EDs).Fig. 1. Schematic diagram of study/referenOn the whole, ICU hospitalizations in Sicily accounted for
3.1% (n ¼ 35,672/1,138,092) of total ED-related admissions
and about 1.7% (n ¼ 622/35,672) included ICD9-CM codes
suggestive of ILI/ARTI in their health records.
During the same period, a total of 253 respiratory samples
were collected from ICU patients with ILI/ARTI. Of these,
233 patients (92.1%) were retrospectively found to match the
inclusion criteria and were included in the final study group.
Therefore, we estimate to have included in the analysis about
40% (n ¼ 233/622) of all Sicilian hospitalized critically ill
patients showing an ILI/ARTI presentation.
Table 1 reports the demographic and clinical characteristics
of ICU hospitalized patients suffering from ILI/ARTI, ac-
cording to the status of infection.
Overall, there were 129/233 (55.4%) males and 104/233
(44.6%) females (ratio M/F ¼ 1.24). Among all patients, 105/
233 (45.1%) were positive for at least one of the selected
pathogens, without difference by sex ( p ¼ 0.27), most of
whom (n ¼ 79/105; 75.2%) had a single infection.
Age ranged between 1 day and 88 years (median 52.9 years,
IQR ¼ 36.6 years). Patients with laboratory-confirmed viral
aetiology were significantly younger than negative subjects
(46.0 years vs. 58.3 years; p < 0.01), but with no significant
age-difference between groups with single and multiple in-
fections (44.6 years vs. 49.4 years; p ¼ 0.59, respectively).ce population inclusion and exclusion.
Table 1
Demographic and clinical characteristics of 233 ICU hospitalized patients in Sicily presenting ILI/ARTI, according to the status of infection. Period: July
2009eDecember 2012.
Characteristics Total (% by column) Negative Positive
(single þ co-infection)
Single infection Co-infection p-value
ICU hospitalized subjects [n(%)] 233 (100.0) 128 (54.9) 105 (45.1) 79 (75.2) 26 (24.8)
Sex [n(%)]
Male 129 (55.4) 75 (58.1) 54 (41.9)b 41 (75.9) 13 (24.1) 0.27b
Female 104 (44.6) 53 (51.0) 51 (49.0)b 38 (74.5) 13 (25.5)
Age [median (IQR), years] 52.9 (36.6) 58.3 (32.5)c 46.0 (47.6)c 44.6 (53.0)d 49.4 (39.4)d <0.01c, 0.59d
Age group (years) [n(%)]
14 41 (17.6) 15 (36.6) 26 (63.4)e 20 (76.9) 6 (23.1) <0.01e
15e64 117 (50.2) 64 (54.7) 53 (45.3)e 41 (77.4) 12 (22.6)
65 75 (32.2) 49 (65.3) 26 (34.7)e 18 (69.2) 8 (30.8)
Length of hospital stay
[median (IQR), days]
18.5 (25) 21 (25)f 18 (28)f 18 (29)g 15 (15)g 0.79f, 0.96g
Adverse outcomes [n(%)]
Pneumonia 162 (69.5)a 87 (53.7) 75 (46.3) 56 (74.7) 19 (25.3)
Respiratory failure 105 (45.1)a 59 (56.2) 46 (43.8) 35 (76.1) 11 (23.9)
ARDS 59 (25.3)a 28 (47.5) 31 (52.5) 24 (77.4) 7 (22.6)
Sepsis/Septic shock 12 (5.2)a 8 (66.7) 4 (33.3) 4 (100.0) 0 (0)
Death 84 (36.1)a 44 (52.4)h 40 (47.6)h 32 (80.0) 8 (20.0) 0.56h
a Percentages are not mutually exclusive; IQR: Interquartile range; ARDS: Acute Respiratory Distress Syndrome.
b p value associated with the comparison of positivity between male and female.
c p value associated with the comparison of median age between negative and positive patients.
d p value associated with the comparison of median age between groups of patients with single or multiple infection.
e p value associated with the test for trend of prevalences of positivity (microorganism detection) vs. age groups.
f p value associated with the comparison of length of hospital stay between negative and positive patients.
g p value associated with the comparison of length of hospital stay between groups of patients with single or multiple infection.
h p value associated with the comparison of median age at death between negative and positive patients.
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all ILI/ARTI cases in Sicily during the study period, higher
positive rates of infection were observed among younger in-
dividuals (63.4%), and the proportion of positive subjects
significantly decreased with age ( p < 0.01).
Length of hospital stay differed neither between negative
and positive patients ( p ¼ 0.79) nor between subjects showing
single or co-infections ( p ¼ 0.96).
Pneumonia was the prevalent adverse outcome (n ¼ 162/
233; 69.5%), followed by respiratory failure (n ¼ 105/233;
45.1%), and acute respiratory distress syndrome (ARDS)
(n ¼ 59/233; 25.3%). Sepsis and/or septic shock was docu-
mented in clinical records of 12/233 (5.2%) ICU-patients.
Eighty-four patients with ILI/ARTI presentation deceased
and no difference was observed in relation to the aetiology
( p ¼ 0.56; 44 vs. 40 deaths among negative and positive
subjects, respectively).
In general, ILI/ARTI cases were reported throughout the
study period, with seasonal influenza confirmed infections
mainly detected during the period OctobereMarch, while
other different viral aetiologies were also found from August
to September and from April to May (for more details see
Supplementary Fig. 1). Supplementary Fig. 2 depicts the
proportions of laboratory-confirmed samples, according the
aforementioned three different age-groups and
microorganisms.
Study population with laboratory-confirmed positivity was
stratified according to a single or a multiple detection (Table
2). About half of all subjects with mono-infections (n ¼ 41/
79; 51.9%) were adults. In general, influenza viruses were themost common aetiologic agents (n ¼ 44/79; 55.7%), and
influenza A(H1N1)pdm09 prevailed, especially among adults
(n ¼ 32/44; 72.7%).
Human parainfluenza viruses and enteroviruses had similar
detection frequencies (13.3% and 11.4%, respectively), six out
of 79 patients (7.6%) were infected with human respiratory
syncytial viruses, while in four patients (5.1%) human coro-
naviruses (n ¼ 2, hCoV-NL63; n ¼ 1, hCoV-HKU1; and
n ¼ 1, hCoV-OC43) were found. Finally, 2/79 subjects (2.5%)
were positive for human rhinovirus, as well as for human
bocavirus type 1; only one patient (1.3%) was positive for
human KI polyomavirus.
AdV, hPeV and WUPyV were not detected at all. Most of
ICU-patients with laboratory-confirmed polymicrobial aeti-
ology (n ¼ 20/26; 76.9%) were adults and elderly (Table 2b).
4. Discussion
During the 4-year period of this study, more than 3 millions
hospitalizations were recorded in Sicily, and the admission
rate to intensive care from EDs documented in our area (3.1%)
is comparable to that reported in other developed countries
[13,14]. However, many differences still remain because of a
high variability of the threshold for ICU-admission, in respect
of intensive care services provided in different healthcare
systems, clinical management strategies of critically ill pa-
tients, resources, and ultimately availability of ICU beds [15].
To date, respiratory infections still represent a major
concern and a leading cause of hospital admission to intensive
care [13,15], although the burden and aetiology of influenza-
Table 2
Distribution of single (a) and multiple aetiology (b) among ICU hospitalized patients in Sicily presenting ILI/ARTI, according to age-group. Period: July 2009 to
December 2012.
ICU hospitalized subjects
Total (% by column) 14 yrs (% by row) 15e64 yrs (% by row) 65 yrs (% by row)
(a) Microorganism: single aetiology [n(%)]
N of infected subjects 79 (100.0) 20 (25.3) 41 (51.9) 18 (22.8)
Influenza viruses 44 (55.7) 9 (20.5) 32 (72.7) 3 (6.8)
A(H1N1)pdm09 41 (51.8) 9 (22.0) 29 (70.7) 3 (7.3)
Type A - untypable 2 (2.5) 0 (0) 2 (100.0) 0 (0)
Type B 1 (1.3) 0 (0) 1 (100.0) 0 (0)
Human parainfluenza viruses (hPIV) 11 (13.9) 3 (27.3) 3 (27.3) 5 (45.5)
hPIV-1 4 (5.1) 2 (50.0) 0 (0) 2 (50.0)
hPIV-2 3 (3.8) 1 (33.3) 1 (33.3) 1 (33.3)
hPIV-3 3 (3.8) 0 (0) 1 (33.3) 2 (66.7)
hPIV-4 1 (1.3) 0 (0) 1 (100.0) 0 (0)
Human enterovirus (hEV) 9 (11.4) 2 (22.2) 4 (44.4) 3 (33.3)
Human respiratory syncytial viruses (hRSV) 6 (7.6) 3 (66.7) 0 (0) 3 (33.3)
hRSV-A 4 (5.1) 1 (25.0) 0 (0) 3 (75.0)
hRSV-B 2 (2.5) 2 (100.0) 0 (0) 0 (0)
Human coronaviruses (hCoV) 4 (5.1) 1 (25.0) 2 (50.0) 1 (25.0)
hCoV-NL63 2 (2.5) 1 (50.0) 1 (50.0) 0 (0)
hCoV-HKU1 1 (1.3) 0 (0) 1 (100.0) 0 (0)
hCoV-OC43 1 (1.3) 0 (0) 0 (0) 1 (100.0)
Human rhinovirus (hRV) 2 (2.5) 1 (50.0) 0 (0) 1 (50.0)
Human bocavirus type 1 (hBoV-1) 2 (2.5) 1 (50.0) 0 (0) 1 (50.0)
Human KI polyomavirus (KIPyV) 1 (1.3) 0 (0) 0 (0) 1 (100.0)
(b) Microorganism: multiple aetiology [n(%)]
N of co-infected subjects 26 (100.0) 6 (23.1) 12 (46.2) 8 (30.8)
Influenza A(H1N1)pdm09 þ
Influenza type C 1 (3.8) 0 (0) 1 (100.0) 0 (0)
hPIV-2 1 (3.8) 0 (0) 1 (100.0) 0 (0)
hPIV-3 1 (3.8) 0 (0) 1 (100.0) 0 (0)
hEV 2 (7.7) 0 (0) 2 (100.0) 0 (0)
hCoV-OC43 2 (7.7) 0 (0) 1 (50.0) 1 (50.0)
hCoV-NL63 1 (3.8) 0 (0) 1 (100.0) 0 (0)
hMPV-A 1 (3.8) 0 (0) 0 (0) 1 (100.0)
hMPV-B 2 (7.7) 0 (0) 2 (100.0) 0 (0)
hRV 1 (3.8) 1 (100.0) 0 (0) 0 (0)
Influenza type A (untypable) þ hMPV-B þ hEV 1 (3.8) 1 (100.0) 0 (0) 0 (0)
Human metapneumoviruses (hMPV)
hMPV-A þ hMPV-B 5 (19.2) 2 (40.0) 1 (20.0) 2 (40.0)
hRSV-A þ hCoV-OC43 1 (3.8) 1 (100.0) 0 (0) 0 (0)
hRSV-B þ hCoV-229E 1 (3.8) 0 (0) 0 (0) 1 (100.0)
hRV þ hEV 3 (11.5) 1 (33.3) 1 (33.3) 1 (33.3)
hPIV-1 þ hRV 1 (3.8) 0 (0) 0 (0) 1 (100.0)
hPIV-3 þ hCoV-OC43 1 (3.8) 0 (0) 0 (0) 1 (100.0)
hPIV-2 þ hMPV-A þ hMPV-B þ hCoV-NL63 1 (3.8) 0 (0) 1 (100.0) 0 (0)
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well-defined [6].
The key finding of this present study was that viral in-
fections affected a large proportion of ICU patients with ILI/
ARTI, and the detection rate of 45.1% in our study population
was significantly higher than previously reported in other
European countries [16].
According to other authors [17], influenza virus was the
most frequently detected microorganism, and coincident
detection of different viral pathogens constituted about 25% of
total infections, fitting well with the results of similar reports
[16].
In this regard, a lower detection rate found in other different
settings of non-ICU hospitalized patients [18], and thepotential synergism between viruses and bacteria, which can
lead to more severe disease and excess mortality [19], un-
derline the importance of a complete microbiological inves-
tigation, particularly in a such group of severely ill patients at
higher risk of death.
Other respiratory pathogens were found in our series, such
as human parainfluenza viruses and coronaviruses (13.3% and
5.1%, respectively), which have also been described to cause
significant symptoms, morbidity and potential need of inten-
sive care treatment [4]. Surprisingly, microorganisms such as
hRV, hRSV, hMPV, commonly reported in several studies and
also responsible for admission to ICU and mortality in the
elderly [6,17], were found at very low prevalences and often
co-detected with other respiratory agents.
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different infectious agents, the knowledge of the circulation of
several types of microorganisms may be essential from the
standpoint of infection prevention and hospital epidemiology,
even more crucially, in intensive care wards. In fact, different
situations may be responsible for healthcare facility outbreaks
of highly transmissible respiratory pathogens. On one hand,
the lack of appropriate isolation strategies of high vulnerable
patients with acute febrile respiratory illness prior to diagnosis
of potentially infectious agent [6,20], and on the other hand,
the very low compliance with vaccination and coverage rates
among HCWs [8,21e23], further worsened by improper be-
haviours such as “presenteeism” (working while ill rather than
take sick leave), which is prevalent among HCWs [9,24],
despite recent recommendation from the Centers for Disease
Control and Prevention on prevention strategies for ILI in
healthcare setting [25].
We are aware of some limitations of this study. First, this
was a descriptive retrospective study and no comparison
groups at different risk were considered in order to evaluate
the potential role of single/multiple aetiology as a cause of
ICU hospitalization and severity of disease.
Second, there was a lack of data regarding bacterial aeti-
ology, which did not allow to detail the co-presence of bac-
terial/viral infections and, consequently, caused an
underestimated infection rate for ICU-patients.
Third, in our setting, oropharyngeal samples were mostly
collected, which more likely represent the microbiota of the
upper airways, being unable to distinguish colonization/
infection of the upper respiratory tract from infections of the
lower airways. Despite it has been hypothesized an agreement
between lower and upper respiratory specimens for the
detection of respiratory pathogens [26], it is very difficult to
formulate assumptions, in some cases, on pathogenicity of
detected microorganisms in the upper respiratory tract [27].
This anatomic site is a reservoir of a diverse community of
commensal germs which, in a dynamic process and because of
individual risk factors or imbalances in the ecosystem, may
change their role to pathogens causing respiratory or invasive
disease, also in immunocompetent subjects. Furthermore,
immunosuppressed subjects or the elderly [19], who may
suffer of pre-existing respiratory tract involvement, pulmonary
and cardiac failure, together with low vaccination coverage
rates [28], can lead to hospitalization and intensive care
treatment.
Nevertheless, despite these limitations, the present study
included both a good representativeness of our geographic
area, although with a moderate sample size, and the use of
comprehensive panel of microorganisms.
Additionally, our study differed from previous published
reports in that our population study also included ILI subjects
rather than only patients with pneumonia or other severe res-
piratory symptoms [29,30] thus depicting the heterogeneity of
respiratory agents circulating in intensive care settings.
Our findings confirm that polymicrobial aetiologies are
common among patients with ILI/ARTI admitted to ICU,
playing a very important role in the overall outcome ofvulnerable patients and representing an unrecognized health
exposure that puts all ICU-admitted patients at risk.
Early recognition of ILI/ARTI aetiology in ICUs is
important in order to implement early infection-control stra-
tegies and to assess of drug therapy appropriateness. The
approach to critically ill patients with respiratory symptoms
needs to evolve to include a public health perspective, also
promoting positive habits among HCWs, in addition to the
focus on individual diagnosis and treatment.
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